![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
20
Arevipharma Gmbh Radebeul De, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Acetylcysteine, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2005-018 - Rev 00
This Chemical Type CEP, issued on April 20, 2011, remains in force until July 12, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 967 associated with this CEP further emphasizes